| |
| |
|
| Insider
Information: |
Harper Philip R |
| Relationship: |
10% Owner |
| City: |
Bethesda |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
4,959,819 |
|
|
Indirect Shares
|
220,000 |
|
|
| Direct
Value |
$917,567 |
|
|
|
Indirect Value
|
$40,700 |
|
|
| Total
Shares |
5,179,819 |
|
|
| Total
Value |
$958,267 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
American Capital Ltd |
ACAS |
Director |
2017-01-03 |
0 |
2017-01-03 |
0 |
Premium* |
|
|
Aevi Genomic Medicine Inc |
GNMX |
10% Owner |
2017-09-01 |
4,959,819 |
2017-09-01 |
220,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
220,000 |
|
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,786,682 |
|
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-22 |
4 |
B |
$1.79 |
$1,790,000 |
D/D |
1,000,000 |
4,786,682 |
2.45 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-23 |
4 |
B |
$1.60 |
$7,528 |
D/D |
4,705 |
4,791,387 |
2.37 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-24 |
4 |
B |
$1.60 |
$86,122 |
D/D |
53,826 |
4,845,213 |
2.45 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-08-10 |
4 |
B |
$1.19 |
$24,359 |
D/D |
20,470 |
4,865,683 |
2.37 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-08-22 |
4 |
B |
$1.20 |
$5,593 |
D/D |
4,661 |
4,870,344 |
2.37 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-08-23 |
4 |
B |
$1.20 |
$6,840 |
D/D |
5,700 |
4,876,044 |
2.37 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-09-01 |
4 |
B |
$1.20 |
$100,530 |
D/D |
83,775 |
4,959,819 |
2.45 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-05-15 |
5 |
OE |
$21.56 |
$36,652 |
D/D |
1,700 |
285,277 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-08-15 |
4 |
B |
$22.25 |
$311,500 |
I/I |
14,000 |
17,000 |
2.1 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-08-15 |
4 |
B |
$22.66 |
$862,788 |
D/D |
37,852 |
187,176 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-08-18 |
4 |
B |
$23.10 |
$462,000 |
D/D |
20,000 |
207,176 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-08-19 |
4 |
B |
$23.30 |
$212,030 |
D/D |
9,100 |
216,276 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-08-20 |
4 |
B |
$24.36 |
$48,720 |
D/D |
2,000 |
218,411 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-08-21 |
4 |
B |
$24.26 |
$34,279 |
D/D |
1,413 |
219,824 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-08-22 |
4 |
B |
$24.11 |
$72,330 |
D/D |
3,000 |
222,824 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-09-10 |
4 |
B |
$25.90 |
$181,300 |
D/D |
7,000 |
254,566 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-09-10 |
4 |
B |
$25.89 |
$338,670 |
D/D |
13,000 |
254,566 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-09-11 |
4 |
B |
$25.89 |
$388,755 |
D/D |
15,000 |
269,566 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-11-18 |
4 |
B |
$27.78 |
$277,800 |
D/D |
10,000 |
279,566 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2003-11-20 |
4 |
B |
$27.60 |
$157,624 |
D/D |
5,711 |
285,277 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2004-11-05 |
4 |
B |
$31.77 |
$953,100 |
D/D |
30,000 |
315,277 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2005-02-23 |
4/A |
GA |
$0.00 |
$0 |
I/I |
59,841 |
76,841 |
|
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2005-02-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
59,841 |
74,841 |
|
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
